Published trade mark details for 2630723
This information was published on 2026-03-27T11:49:22 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2630723 (IR 1904733) |
| (220) |
16 Jan 2026
|
| (300) |
US, 27 Aug 2025, 99359933
|
| (500) |
The mark consists of the wording "KYGEVVI" in stylized font with the lettering appearing in a turquoise font.
Turquoise. The mark consists of the wording "KYGEVVI" in stylized font with the lettering appearing in a turquoise font. |
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of tk2 gene diseases and disorders, mitochondrial depletion syndrome disease and disorders, and enzyme deficiency diseases and disorders. |
| (540) |
|
| (730) |
UCB Biosciences Inc.
|
Find out more about publications on the About page.